140 related articles for article (PubMed ID: 35774798)
1. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis.
Wu L; Sun S; Qu F; Liu X; Sun M; Pan Y; Zheng Y; Su G
Front Immunol; 2022; 13():829640. PubMed ID: 35774798
[TBL] [Abstract][Full Text] [Related]
2. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
Sun Z; Li G; Shang D; Zhang J; Ai L; Liu M
Front Immunol; 2022; 13():988303. PubMed ID: 36275690
[TBL] [Abstract][Full Text] [Related]
3. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer.
Lin H; Cao B
Dis Markers; 2022; 2022():3592990. PubMed ID: 35937946
[TBL] [Abstract][Full Text] [Related]
4. ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer.
Zhang D; Ni QQ; Liang QY; He LL; Qiu BW; Zhang LJ; Mou TY; Le CC; Huang Y; Li TT; Wang SY; Ding YQ; Jiao HL; Ye YP
Oncogene; 2023 Sep; 42(38):2841-2853. PubMed ID: 37591954
[TBL] [Abstract][Full Text] [Related]
5. Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status.
Mou W; Zhu L; Yang T; Lin A; Lyu Q; Guo L; Liu Z; Cheng Q; Zhang J; Luo P
Cancer Cell Int; 2022 Jul; 22(1):229. PubMed ID: 35836254
[TBL] [Abstract][Full Text] [Related]
6. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
Ji J; Liu S; Liang Y; Zheng G
BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
[TBL] [Abstract][Full Text] [Related]
9. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma.
Jiang Z; Xu J; Zhang S; Lan H; Bao Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10813-10829. PubMed ID: 37316691
[TBL] [Abstract][Full Text] [Related]
10. Glutathione peroxidase 2: A key factor in the development of microsatellite instability in colon cancer.
Cui Z; Xu L; Wu H; Wang M; Lu L; Wu S
Pathol Res Pract; 2023 Mar; 243():154372. PubMed ID: 36796200
[TBL] [Abstract][Full Text] [Related]
11. Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients.
Yue T; Cai Y; Zhu J; Liu Y; Chen S; Wang P; Rong L
Front Immunol; 2023; 14():1064704. PubMed ID: 36756126
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-associated gene CISD2 suppresses colon cancer development by regulating tumor immune microenvironment.
Xu Y; Tang Q; Ding N; Zhang T; Luo H
PeerJ; 2023; 11():e15476. PubMed ID: 37304867
[TBL] [Abstract][Full Text] [Related]
13. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
14. Achaete-scute complex-like 2 regulated inflammatory mechanism through Toll-like receptor 4 activating in stomach adenocarcinoma.
Zheng E; Cai Z; Li W; Ni C; Fang Q
World J Surg Oncol; 2022 Aug; 20(1):266. PubMed ID: 36008864
[TBL] [Abstract][Full Text] [Related]
15. Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy.
Xu M; Chang J; Wang W; Wang X; Wang X; Weng W; Tan C; Zhang M; Ni S; Wang L; Huang Z; Deng Z; Li W; Huang D; Sheng W
Front Immunol; 2022; 13():934083. PubMed ID: 35967414
[TBL] [Abstract][Full Text] [Related]
16. Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma.
Zheng L; Zhang J; Ye Y; Shi Z; Huang Y; Zhang M; Gui Z; Li P; Qin H; Sun W; Zhang M
Aging (Albany NY); 2023 Sep; 15(18):9521-9543. PubMed ID: 37724904
[TBL] [Abstract][Full Text] [Related]
17. Exploration of an Prognostic Signature Related to Endoplasmic Reticulum Stress in Colorectal Adenocarcinoma and Their Response Targeting Immunotherapy.
Xu Y; Xie YM; Sun WS; Zi R; Lu HQ; Xiao L; Gong KM; Guo SK
Technol Cancer Res Treat; 2023; 22():15330338231212073. PubMed ID: 37920989
[No Abstract] [Full Text] [Related]
18. Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
Kang M; Su Z
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36799193
[TBL] [Abstract][Full Text] [Related]
19. Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients.
Shen X; Zuo X; Liang L; Wang L; Luo B
Front Immunol; 2023; 14():1162843. PubMed ID: 37207222
[TBL] [Abstract][Full Text] [Related]
20. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
Cui Y; Lv P; Zhang C
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
